Thursday, 15th February 14th Lorne Infection and Immunity 2024

• Malaria sporozoite biology at the dermal inoculation site - Photini Sinnis
• Non-antibiotic strategies to mitigate enteric infections: insights from discovery research - Dena Lyras
• Utilising the tick’s trick for advancing anti-inflammatory therapy - Shankar Devkota
• New molecular mechanisms for bacterial toxins - Jason J Paxman
• Targeted degradation of host messenger RNA by a bacterial effector modulates macrophage metabolism - Kitty McCaffrey
• Group A Streptococcus associated with recurrent tonsillitis form antibiotic-resistant intracellular communities - Tim Barnett
• Gut inflammation and barrier breakdown in severe dengue disease - Katryn Stacey

• Understanding the distinct roles of IFN epsilon in protecting the mucosa from disease - Paul Hertzog
• Potent, HIV-specific latency-reversal through CRISPR activation delivered by lipid nanoparticles - Paula M Cevaal

• Developing a functional cure for HTLV1 in a humanized mouse model - Marcel Doerflinger
• Resistance to last line antibiotics impairs STING-dependent sensing of MRSA in dendritic cells. - Meredith O'Keeffe
• Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 COVID-19 vaccines - Nicole L Messina
• Influenza vaccine responses to A(H1N1)pdm09 antigens in 2020 and 2021 among repeatedly vaccinated healthcare workers - Stephany Sanchez-Ovando
• Can a meningococcal vaccine prevent gonorrhoea? - Kate L Seib
• Trafficking towards antimicrobials - Joen Luirink

• Antibody-mediated enhancement of Pseudomonas aeruginosa acute and chronic infections - Timothy J Wells
• Stromal-Immune interactions regulating pulmonary immunity - Clare Lloyd
• Glycolysis of airway macrophages controls lung homeostasis and responses to aeroallergen - Gesa J Albers
• Defining pro-inflammatory antibody effector functions during viral infection - Larisa Labzin
• A1 is induced by pathogen ligands to limit myeloid cell death and NLRP3 inflammasome activation - Kate E Lawlor
• Interferon epsilon as a novel anti-viral agent in the testis - Rukmali Wijayarathna

• Modelling & Targeting Cytokine Storm in Dengue Virus-infected Mice - William Clow
• Understanding the AhR and innate immunity axis in RNA virus infection - Xavier B Montin
• Developing a microbial therapeutic for the prevention of systemic Candida albicans infections arising from the gastrointestinal tract - Bianca Briscas
• Exploring connections between mitochondrial fission and lipid droplets in macrophage inflammatory and antimicrobial pathways - Karoline D Raven
• Exploration of the Immunostimulatory Effects of Group A Streptococcus Pili - Risa Takahashi
• Enterococcus faecalis exploit neutrophils as an intracellular niche for replication and persistence - Claudia J Stocks
• Serological profiling of viral infection using peptide phage display - Li Chen Cheah
• Human Immunodeficiecny Virus-1 (HIV-1) Neutralisation Profiles in HIV-1 Viremia Suppressed Nepalese Individuals - Anurag Adhikari
• Molecular and cellular pathogenesis of Ross River virus - Nicholas Yuen

• Characterising the quick-killing mechanism of action of azithromycin analogues against malaria parasites - Emma Mao
• Dead or alive? Unveiling the Molecular Mechanisms of SARS-CoV-2 Pathogenesis in vivo - Stefanie M. Bader
• SpoT-mediated unique metabolic remodelling potentially underlies polymyxin tolerance in Acinetobacter baumannii - Zhi Ying Kho
• Developing precision RNA therapeutics for Tuberculosis - Jan Schaefer
• 3-base long 2’O-methyl oligonucleotides are potent TLR7 and TLR8 modulators. - Sunil Sapkota
• Development and characterisation of a SARS-CoV-2 RNA vaccine expressing three linked-RBD domains  - Yadana Zaw
• Understanding the enhanced immune responses to high-density microarray patch vaccination through spatial transcriptomics - Christopher McMillan
• Cytostome formation in artemisinin resistant Plasmodium parasites - Long Huynh
• Just the Tipα of the iceberg: nuclear targeting by an Helicobacter pylori extracellular vesicle-associated toxin. - Jack Emery

Venue: The Common at Lorne Oval, 45 Otway St, Lorne
Date: Thursday 15th February 2024
Time: 6:00 PM - 8:00 PM
Cost: General delegates - $70, Students - $40 - Additional ticket $70

This ticket includes one drink. Additional drinks are available for purchase separately at the venue.

All special dietary requirements will be accommodated. 

• Development of ex vivo models of nasal epithelia to elucidate the mechanism of Bordetella bronchispetica-mediated blockade of influenza virus replication in the nasal cavity. - Jasmina M Luczo
• Genital InFlammation Test (GIFT) for sexual and reproductive health: point-of-care screening tool for sexually transmitted infections and bacterial vaginosis - Lindi Masson
• Improving plasmapheresis: Novel avenues for treating cloaking antibodies - Joshua N Monteith
• Investigation of the immune evasion function of interferon antagonists of different Hendra virus genotypes - Gregory W Moseley
• Insights into the role of ribose metabolism for the virulence and persistence of Haemophilus influenzae in the host - Saurab Kishore Munshi
• The MIF Myth + post-docs at CSIRO - Tim Muusse
• Exploring targeted immunomodulation as a treatment for legionella induced pneumonia - Joshua M Nickson
• Redox-adapted macrophages evade ferroptosis in tumor microenvironments - Patricia P Ogger
• Inhibition of interferon induction by P protein isoforms of rabies virus fixed and street strains - Kazuma Okada
• Molecular basis for neutralization of the bacterial type I restriction-modification system by a phage protein - Suk-Youl Park
• The effects of megadose sodium ascorbate (vitamin C) on bacterial clearance and immune function in rodent sepsis  - Rachel M Peiris
• TREML4 ablated mice develop protection against lethal Candida albicans secondary infection following polymicrobial sepsis - Corey Pollock
• Targeting toll-like receptor 9 signalling with a flavonoid-derived novel small molecule - Refaya Rezwan
• Gasdermin D deficiency limits the severity of pulmonary disease during influenza A virus infection - Sarah Rosli
• TLR4 endocytosis is dissociable from Type I IFN expression but requires TLR4 activation and ubiquitin ligase activity - Thomas E Schultz
• How does rabies virus prevent the production of interferon? - Hudson A Smith
• Leveraging genome-based phylogenies to associate bacterial clades with host molecular responses in inflammatory bowel disease - Sean Solari
• Zinc acquisition and its contribution to Klebsiella pneumoniae virulence - Aimee Tan
• Modelling infection in an ex vivo precision-cut lung slice model of chronic obstructive pulmonary disease - Belinda J Thomas
• A new fluorescent tool to investigate a novel KoRV-related bat retrovirus - Shuoshuo Tian
• Promoting extrinsic apoptosis to diminish latent HIV reservoir in vivo - Le Wang
• CRISPR diagnostics: The versatile, rapid & accurate detection of pathogens - Lewis Williams
• Seroprevalence and risk factors of flavivirus infections in horses in South-East Queensland post Japanese encephalitis virus incursion - Nicholas Yuen
• Integrating Artificial Intelligence into Stemformatics: Identifying Influential Variables in Stem Cell Biology through Enhanced Data Curation and Deep Learning - Chen Zhan